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1. INTRODUCTION
Planet Earth has more than 50 million species of plants, animals and 
micro-organism and hardly two million of them have been described by man 
so far. Out of 4,80,000 species of plants only 3,22,311 have been identified. 
India is the one of 12 mega biodiversity of world accounts for 7-8 % of 
recorded species of world. Over 47,000 species of plants have been invented 
in India and National Bureau of plant genetic resources has a collection of 
over 1,59,080 varieties.1 
          As per an estimate 80,000 species out of nearly 2,50,000 globally 
occurring species bear medicinal and aromatic value.
          Out of presently available species of plants, 75 major species of  
medicinal flora have been highlighted and 25 out of these are most sought 
after during the last decade.2 
          India is the most important medicinal plant resources collection 
centers  of  the  world.  Over  500  million  people  receive  the  benefits  of 
traditional  knowledge  of  well  documented  and  standardized  systems  of 
medicines including Sidha, Unani and Ayurveda, etc. 
          India has 4,60,000 practitioners of traditional system of medicines in 
India,  as  per  an  estimate,  out  of  this  2,71,000  are  registered  and  7,843 
licensed manufacturer of traditional drugs.6
          In a review of data between 1994-1998, it was found that there is a 
growing interest in correlating phytochemical constituents of a plant with its 
pharmacological activity.3
          Utilization of technological advances, a logical interpretation of the 
codified language of traditional medicine also becomes a necessity in order 
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to further promote research in field. ‘Rasayana’ is a good example of this, as 
it  is  attempted  to  interpret  the  word  'Rasayana'  in  modern  scientific 
terminology and taking into consideration the advocated uses for this group 
of plants as per Ayurvedic textbooks while designing their research protocol. 
However limitations in research are -
 Inadequate information on procedures adopted for quality assurance is 
not provided in majority of articles. 
 Research  areas  like  tuberculosis,  malaria,  diarrhoea,  AIDS,  and 
malnutrition  which  are  major  problems  of  our  country  are  not 
extensively explored. 
 Only few drug at experimental  stages,  were undertaken for  clinical 
trial. 
 Studies regarding drug interaction, adverse drug reaction are sparse.3
               Archaeological evidence reveals that drug taking is an extremely  
old  human  phenomenon  and  by  necessity,  the  drugs  used  in  ancient 
civilization were extracts of plants or animal products. However, the use of 
discovery of medicinal property of plant parts, animal parts or of mineral 
origin was by chance or by hit and trial, this knowledge at one hand was 
transferred from generation to generation and constitutes folklore medicinal 
or home remedies. The same knowledge, on other hand was utilized, tried 
and reported by ancient physicians in their manuscripts.6
Ayurvedic which means science of life is Upveda of Atharva Veda,one 
out of four Vedas written by Aryans. Charak Samhita (1900 BC) is the first 
recorded treatise fully devoted to the concepts of practice of Ayurveda, has 
description of 341 plants and plant product for use in medicine. The next 
landmark of Ayurvedic literature was Sushruta Samhita (600 BC), which has 
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special  emphasis on surgery, described 395 medicinal  plants,  57 drugs of 
animal origin, 64 minerals and metals as therapeutic agents.6 
Around 17th century AD, Bagbahtta of Sind, wrote Astanga Hridya, on 
principles and practice of medicine.
Madhab  Nidana  (800-900  AD)  is  another  milestone  describing 
diagnosis of diseases as per Ayurvedic concept, Bhava Mishra in 1550 wrote 
Bhava Prakasha with description of 470 medicinal plants. 
Ayurveda, an ancient Indian system of health care involving holistic 
view of man, his health and illness and treatment consists of Salubrious use 
of drugs, diets and certain practices. Medicinal preparations are invariably 
complex  mixtures,  based  on  plant  products.  Around  1250  plants  are 
currently used in various Ayurvedic  preparations.  Many Indian medicinal 
plants have come under scientific scrutiny since the middle of nineteenth 
century,  although in  a  sporadic  fashion.  The first  significant  contribution 
from Ayurvedic  Materia  Medica  came with  the  isolation  of  hypertensive 
alkaloid  reserpine  from  the  Sarpagandha  plant  (Rauwolfia  serpentina), 
valued in Ayurveda for the treatment of hypertension, insomnia and insanity. 
This  was  the  first  important  ancient-modern  concordance  in  Ayurvedic 
plants.6
With advancement in chemistry and biology, disciplines central to the 
study  of  biological  activities  of  natural  products,  many  Ayurvedic  plants 
have been reinvestigated. 
In  the  early  development  of  modern  medicine,  biologically  active 
compounds  from  higher  plants  have  played  a  vital  role  in  providing 
medicines to combat pain and diseases. In British Pharmacopoeia of 1932, 
over 70% of organic monographs were on plant derived products. 
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However with the advent of synthetic medicinal and antibiotics, the 
role of plant derived therapeutic agents significantly declined, thus in 1980 
edition of British Pharmacopoeia, the share of plant-based monographs fell 
to  approximately  20%  and  out  of  new  chemical  entities  introduced  as 
medicinal agents the share of plant-based drugs was not more than 2%..6
The  practical  aspect  of  using  synthetic  drugs  was  that  only  one 
molecule  out  of  the 1000 synthesized came into usage for  patients,  after 
incurring  a  heavy  Research  and  development  expenditures,  with  lots  of 
investment in terms of time and labour. 
In spite of these,  withdrawal rate of new synthetics has been high, 
may  be  because  of  long-term  side  effects,  safety  data,  emergence  of 
resistance and many other reasons.  This  phenomenon has led researchers 
back into the field of plant-based drugs. Now Investigations and use of plant 
based material is  on single plant extracts or fractions thereof. These new 
plant  derived  products,  if  need  be,  are  used  as  lead  structures  also,  are 
carefully standardized and their efficacy and safety for a specific application 
have been demonstrated.  Thus plant  based therapeutic agents continue to 
have significance and appear to be gathering momentum in health related 
areas.10
With advancement of technology, now it is possible to approach the 
study  of  medicinal  plants  from  the  botanical,  phytochemical  and 
pharmacological point of view. The use of modern isolation technology and 
pharmacological testing procedures means that new plant drugs usually find 
their way into medicine as purified substances rather than in the form of 
Galenical preparation.5
Plant  Kingdom  still  holds  many  species  of  plants  containing 
substances  of  medicinal  value,  which  have  yet  to  be  discovered,  large 
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numbers  of  plants  are  constantly  being  screened  for  their  possible 
pharmacological value. The wealth of uninvestigated plant material available 
can  be  illustrated  by  the  fact  than  in  1985,  out  of  3500  new  chemical 
structures from natural products, 2600 were from higher plants.
Mentioned  below  are  some  drugs  of  natural  origin,  which  have 
become drug over choice because of their efficacy and safety over currently 
available drugs: 
 Mevastatin  (compactin)  isolated  from Penicillin  sp.,  and  lovastatin 
and simvastatin. 
 Qunine- still preferred drug against P. falciparum 
 Penicillin, Cephalosporins, Vancomycins 
 Artemisinin  and  its  derivatives-.  Artisuanate,  Artemether,  Arteether 
and Sodium. 
 Immunosuppressants - Cyclosporin and Rapamycin 
 Prolactin secretion inhibitor - Ergoline, Terguride 
 Anticancer  -  Vinblastine,  Vircristine,  Etoposide,  Teniposide, 
Paclitaxel, Topotecan4,5
All  research  programs  that  aim  to  discover  novel  bioactive 
compounds from natural sources relay to some degree on the assumption 
that a carefully reasoned philosophy guiding the selection of species to be 
sampled can improve the rate of discovery. The geographic and taxonomic 
distribution of 2,50,000 species of higher plant is not random, the chemistry 
of various plant  families  is  known to differ  significantly and our present 
state of knowledge of chemistry of plants remain uneven. 
Collection  for  screening  may  be  random or  guided  by  Taxonomy, 
Phytochemistry, Ethanobotany, or Zoopharmacology (how certain animals 
utilize plants). 
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It is observed that Ethanobotanically guided collections has yielded 
higher rates than other sampling strategy but has two problems, first they are 
based on relatively small set of data and results though suggestive, are not 
statistically significant, and secondly, they are based on analysis of rates of 
positive results in primary screen.5,7
In general,  natural  drug substances offer  four vital  and appreciable 
role in the modern system of medicine thereby adequately justifying their 
legitimate presence in the prevailing therapeutic arsenal namely- 
 Serve as extremely useful natural drugs: e.g. Atropine, Ergotamine, 
morphine, etc. 
 Provide basic compounds affording less toxic and more effective 
drug  molecules:  Morphine  (natural),  hydromorphine 
(semisynthetic),  methadone  (synthetic),  ephedrine  (natural), 
phenylpropanolamine (semisynthetic), tetrahydrozoline(synthetic).
 Exploration of biologically active prototypes towards newer and 
better synthetic drugs : Procaine from cocaine, chloroquinine from 
quinine 
 Modification  of  inactive  natural  products  by  suitable 
biological/chemical  means  into  potent  drug:  Taxol  from  10-
Dasacetylbaccatin  III,  Progesterone  and  Pregnenolone  from 
diosgenin.10
As per global survey by World Health Organization (WHO), around 
20,000 medicinal plants are being used profusely either in Pharmaceutical 
industry or in folk medicine. Interestingly about 1.4% does possess well-
established widely unequivocally active constituents. The figure on the next 
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page illustrates schematic development of a drug from a “medicinal plant” 
that may serve as a fruitful guide for various phytochemical studies.9
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2. LITERATURE REVIEW
Systemic literature review is the basis for planning a scientific work. In this 
section review of literature of  Butea monosperma (L) Toub  under various 
heading  have  been  carried  out.  They  are  Pharmacognostical  review, 
Phytochemical review, Pharmacological review, Ethanomedical review and 
miscellaneous review. Some of the pioneering work in this field is given 
below.
2.1 Pharmacognostical Review:  
 Burli DA and Khada A (2007):- A comprehensive pharmacognostical 
review on Butea monosperma (Lam.) Kuntze.11
 Shome U, Khanna RK et al (1980):-  Pharmacognostical characters of 
Butea  monosperma  flowers  including  epidermal  and  anatomical 
characters of the flower parts, phytochemical tests, fluorescence tests 
and TLC of different extractive have been reported.12
 Laghate PV, Grampurohit et al (2003):- Reported pharmacognostical 
and phytochemical investigation on the roots of  Butea monosperma 
(Lam.) Taubz.13
2.2 Phytochemical Review:
 Jain SC,  Kamal  R et  al  (1980):- Identified by co-  TLC in various 
solvents and other spectral properties.14
 Yadav AS, Mishra GP (1983):- Studied color & pH of seeds / fruit 
leachate of Butea monosperma.15
 Wagner  H,  Geyer  B  et  al  (1986):-  Reported  qualitative  and 
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quantitative  analysis  of  isobutrin  and  butein  in  extract  of  Butea 
monosperma flowers.16
 Porwal M, Sharma S et al (1988):- Isolated & Identification of a new 
derivative of allophonic acid as 2-hydroxy-omega methyl allophonic 
acid  (as  methyl  ester)  from the   seed  coat  of  Butea  monosperma 
(Lam) Kuntze.17
 Mishra, Shukla YN et al (2000):- Isolated two new compounds from 
the stems of  Butea monosperma  have been characterized as 3-alpha 
hydroxyeuph-25-ene and 2,14-dihydroxy-11,12-dimethoxy-octadec II- 
encyclohexane by spectral data and chemical studies.18
 Mishra,  Shukla  YN  et  al  (2000):- Identified  flavanoids  from 
methanolic  extract  of  Butea monosperma  flowers as  butrin,  butein, 
3,4,7-trihydroxy flavone and stigmasterol-3 beta-D-glucopyranoside.19
 Shukla YN, Mishra M (2000):- Identified two novel compounds from 
Butea monosperma leaves as 3,9-dimethoxypterocaopan and 3-alpha-
hydroxyeuph-25-enylhepta-cosanoate.20
 Shukla  YN,  Mishra  M (2002):- Identified  &  Isolated  pterocarpan, 
phenol and lipid constituents from Butea monosperma stem.21
 Shukla  YN,  Mishra  M  (2000):- Isolated  &  Identified  Euphane 
triterpenoid ester and pterocarpan from Butea monosperma leaves.22
2.3 Pharmacological Review: 
 Gunakkunru K, Padmanaban et al (2005):- Reported anti-diarrhoeal 
potential of the ethanolic extract of stem bark of Butea monosperma 
(Lam) Huntz has been evaluated using several experimental models in 
wistar albino rats.23
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 Miriyala  Sumitra,  Panchatcharam  Manikandan  et  al  (2005):- have 
reported efficacy of  Butea monosperma  on dermal would healing in 
rats.24
 Veena S, Kasture SB et al (2002):- Reported anticonvulsive activity of 
Butea monosperma  flowers in laboratories animals.25
 Zaqar Iqbal, Muhammad lateef et al (2006):- have reported In vivo 
anthelmintic  activity  of  Butea monosperma  against  trichostrongylid 
nematodes in sheep.26
 J.H.  Bavarva,  Narasimhacharya  (2008):- have  reported  preliminary 
study on antihyperglycemic and antihyperlipidemic effects of  Butea 
monosperma in NIDDM rats.27
 Shahavi  VM,  Desai  SK  (2008):- have  reported  anti-inflammatory 
activity of  Butea monosperma flowers, studied methanolic extract of 
Butea monosperma  flowers (MEBM) for anti  inflammatory activity 
against carageenan induced paw edema and cotton pellet granuloma in 
albino rats.28
 Prashanth D,  Asha MK et  al  (2001):- have reported  that  methanol 
extract of Butea monosperma seeds, tested in vitro showed, significant 
anthelmintic activity.29
 Bhatwadekar  AD,  Chintawar  SD  et  al  (1999):- have  reported 
Antistress activity of Butea monosperma flowers.30
 Chauhan  S,  Mathur  R.  (1995):- reported  Antifertility  activity  of 
ethanolic extract of Butea monosperma flowers in male rats.31
 Gawal  NS,  Pal  SC et  al  (2007):- studied effect  of  extract  of  dried 
flowers of Butea monosperma on memory and behavior mediated via 
monoamino neurotransmitters in laboratory animals.32
 Prajapati ML, Sharma AK et al (2000):- Conducted clinical evaluation 
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of palasha pushpadi churna, (Butea monosperma  flowers powder) in 
the management of Diabetes mellitus.33
2.4 Ethnomedicinal review:
 Baillore  KV,  Audichya  KC  (1978):- was  observed  during  a  field 
survey  in  tribal  areas  of  Rajasthan  and  Gujarat  that  Butea 
monosperma was being used as contraceptive drug.34
 Garg SK, Mathur VS et al (1978):- have reported antifertility activity 
of seeds of Butea monosperma.35
 Shaw  BP,Tripathi  AK.  (1982):- Reported  anthelmintic  activity  of 
crude powdered seeds of Butea monosperma. 36
 Phadke UR,Ghooi RB (1983):- Reported Sodium salts of the phenolic 
constituents from the bark of  Butea monosperma show antiasthmatic 
activity.37
 Mehta  BK,  Dubey  A  (1983):- Observed  significant  antifertility 
activity in the alcoholic extract of the outer seed coat and seed powder 
of Butea monosperma.38
 Ansari NA, Rastogi SK et al (1984):- reported Preliminary study of 
aqueous  extract  of  Butea  monosperma  Seeds  for  anthelmintic 
activity.39
 Agarwal AK, Singh M et al (1994):- Reported that pipali rasayana an 
Ayurvedic  herbal  medicine,  prepared  from  Butea  monosperma 
Prescribed for the treatment of chronic dysentery and warm infection 
was tested for anti-giardial and immuno stimulatory activity in mice, 
infected with Giardia lamblia trophozoites.40
 Choudhary  RR  (1995):- Reported  regulation  of  fertility  by  plant 
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product – theme talk of Butea monosperma.41 
 Basu  R,  Mukherjee  PK (1999):- Reported  that  Butea  monosperma 
used for lac culture by the tribals of Purulia in West Bengal.42
 Agarwal  AK (2000) :-  developed  Ayurvedic  preparation  by  giving 
bhavna to piper longum fruit  powder with Ash (Bhasma) of  Butea 
monosperma  resulted  into  remarkable  potentiation  of  antigiardiac 
effect.43
 Kumar KV, Malhotra D et  al  (2001):- Conducted survey on ethno-
medico-botanical of Butea monosperma used by the tribals of sehore 
district of M.P. for curing various ailments.44
 Pandey HP (2001):- Reported that seed oil of Butea monosperma used 
as a traditional several toner and contraceptive.45
2.5 Miscellaneous review:
 Verma R (1982):- Butea monosperma  has been discussed under the 
following headings: local names, phytography botany, phytochemistry 
and phytopharmacology.46
 Prasad UN (1982):- Butea monosperma tree with pale-yellow flowers 
has been reported for the first time.47
 Khare PK, Mishra GP (1981):- Observed relative growth performance 
of seedling of  Butea monosperma (Lam) Taub in three artificial soil 
types.48
 Jain S, Joshi IJ et al  (1983):- Reported cingulata (A New leaf spot 
disease) on Butea monosperma.49
 Purohit  M,  Jamaluddin  (1988):- Found  Twin  and  tricotyledonous 
seedling (Abnormal seedling) of Butea monosperma.50
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 Kulkarni N, Joshi KC (1995):- First report of spodoptera litura (Fab) 
boursin (Lepidoptera: Noctuidae) as a pest on Butea monosperma (L) 
Toub.51
 Upadhya AS, Kumbhojkar MS (1997):- Observed during the medico 
botanical  survey  that  tribal  communities  use  leaves  of  Butea 
monosperma during worship.52
 Verma M, Shukla YN (1998):- Provided a review on the chemistry, 
biological  activities,  biology,  cultivation  and  use  of  Butea 
monosperma.53
 Purohit M, Jamaluddin et al (1998):- Studied germination percentage, 
seed borne fungi  and effect  of  different  fungicides  on seed borne 
fungi of freshly collected seeds of Butea monosperma.54
 Gupta  S,  Khan  R  (2003):- Developed  the  Nursery  techniques  of 
Butea monosperma plants in vidhyan and central plains of U.P.55
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3. RESEARCH ENVISAGED
3.1 Aim of present study:
 In recent years there has been a tremendous increase in demand for 
herbal drugs due to its safety, efficacy and better therapeutic results. Due to 
its  economic pricing as compared to synthetic or  allopathic drugs,  which 
have several therapeutic complications.
    As we know that everything in this world change time by time, since 
thousands of year the era was of Ayurveda or herbal origin drug.  But last 
few decades it was replaced by allopathic system of medicine, which was 
rapidly accepted world wide, but latter due to its lots of adverse effect, again 
men  step  down on Ayurveda because  of  its  better  therapeutic  result  and 
safety profile and now the people are more believing in natural origin drug.
Numerous drugs have been entered in the international pharmacopoeia 
through the study of ethanopharmacology and traditional  medicines.   For 
Ayurveda  and  other  traditional  medicines  newer  guidelines  of 
standardization, manufacture and quality control are required.  Employing a 
unique holistic approach, Ayurvedic medicines are usually customized to an 
individual constitution. Traditional knowledge driven drug development can 
follow  a  reverse  pharmacology  path  and  reduce  time  and  cost  of 
development.   Powerful  new technologies,  such  as  automated  separation 
techniques,  high  throughput  screening  and  combination  chemistry  are 
revolutionizing  drug  discovery.   Traditional  knowledge  will  serve  as  a 
powerful  search  engine  and  most  importantly,  will  greatly  facilitate 
international  focused  and  safe  natural  product  research  to  rediscover  the 
drug discovery process.
Looking to the scope of herbal drug and increasing demand especially 
in  disease  of  liver,  hypertension,  diabetes,  cancer,  renal  diseases, 
inflammation, infectious diseases,  arthritis and skin disease etc., hence, it is 
planned  here  to  study  the  plant  like  Butea  monosperma  (L)  Toub The 
selection of the plant Butea monosperma (L) Toub was made on the basis of 
its
 Easy availability
 Therapeutic value
 Degree of research work which is not done
 Useful chemical constitute present
          Keeping in mind about the adverse effects of allopathic drugs like anti 
diabetics,  anti  pyretic  and  anti-inflammatory,  above  said  activity  were 
studied  with  different  parameters  in  order  to  give  possible  scientific 
validation.
3.2 Plant Collection and Identification:
The  plant  Butea  monosperma  (L)  Toub  belonging  to  family 
“Fabaceae” are widely available in Tamilnadu. For present work the plant 
Butea monosperma (L) Toub. was collected in the month of July 2008, from 
Orakadam forest near Chennai.
Taxonomical Identification:
The plant was identified by Dr P. Jayaraman, Botanist, Plant Anatomy 
Research  Centre  (PARC),  West  Tambaram,  Chennai  by  specimen  no. 
PARC/2008/241. 
Treatment :
The  leaves  were  collected  and washed with  water  and dried.  It  in 
sunlight one hour and then it  was dried in shade. The aerial pieces were 
powdered by means of a wood-grinder and the powder was passed through 
the sieve no.60 for powder analysis and the coarse fraction was subjected for 
phytochemical studies. 
3.3 Plan of work:
 The plan of work of the Leaves of  Butea monosperma (L) Toub was 
carried out as follow:
1. Pharmacognostical Evaluation:
A.  Macroscopical Studies.
B.  Microscopical Studies.
C.   Physico-chemical constants:.
              a. Ash values.
              b. Extractive values.
              c. Loss on drying.
D.  Foaming index.
E.   Fluorescence analysis.
2. Preliminary Phytochemical Evaluation:
A. Purification of solvents.
B. Preparation of extracts.
C. Qualitative phytochemical analysis.
D. Chromatographic studies:             
          a. Thin layer Chromatography.
                b. High Performance Thin Layer Chromatography.
3. Pharmacological Studies:
a. Acute oral toxicity study 
b. Antidiabetic activity
c. Anti-inflammatory activity
d. Antipyretic activity
4. BOTANICAL INFORMATION
4.1 Scientific Name:        Butea monosperma (L) Toub
4.2 Synonym:   Erythrima  monosperma  Lam.,  Butea  frondosa  
                                          Koen.
4.3 Taxonomy:
Kingdom         -         Plantae
Subkingdom        -        Tracheobionta
Division         -        Magnoliophyta
Class                   -        Magniloipsida
Subclass         -        Rosidae
Order         -        Fabalesa
Family                  -       Fabaceae
Genus                   -       Butea
Species                 -       monosperma (L) Toub.
  
4.4 Vernacular Names:
Latin                      -       Butea monosperma
          Tamil -       Parasa
          English                   -       Butea Gum Tree
          Sanskrit                  -       Palasha
          Hindi                      -       Dhak
          Gujrati                    -       Kesudo
          Kannad                   -       Muttuga
          Oriya                      -       Porasu
          Telgu                      -       Moduga
                      
4.5 Occurrence:
Grow gregariously on open grassland and scattered in mixed forest. 
Plantation can be raised both on irrigating and dry lands.
4.6 Distribution: 
Asia Tropical: Pakistan, Srilanka, Mayanmar, Thailand, Vietnam and 
in warmer parts of India.
4.7 Ethanomedical Information:
A red  juice  exudes  from  natural  cracks  and  also  from  artificial 
incisions in the bark.  The fresh juice is applied to ulcers and in relaxed, 
congested and septic  sore throat.  The gum is  a  powerful  astringent;  it  is 
given internally for diarrhoea and dysentery, phthisis and haemorrahge from 
stomach  and  bladder,  its  infusion  is  occasionally  employed  as  a  local 
application in leucorrhoea. A solution of the gum is applied to bruises and 
erysipelatous inflammations and ringworm. 
The bark is reported to posses astringent, bitter, pungent, alterative, 
aphrodisiac and anthelmintic properties. It is useful in tumors, bleeding piles 
and ulcers. The decoction is prescribed in cold, cough, fever, various forms 
of hemorrhages, in menstrual disorders and in the preparation of tonics and 
elixirs, an alcoholic extract of the bark is reported to inhibit the activity of 
Escherichia  coli and  Micrococcus  pyogenes var.  aureus.  A  fraction, 
containing the sodium salt of phenolic constituents, isolated from the bark, 
has shown potential as an anti-asthmatic agent in experimental animal.
The roots are useful in elephantiasis, and in curing night blindness and 
other defects of sight. They are also reported to cause temporary sterility in 
women.
The green leaves are commonly lopped for fodder. The yield of milk 
in buffaloes, fed with Butea leaves, is reported to improve. They are credited 
with astringent, tonic, diuretic and pimples and tumorous haemorrhoids and 
are internally given in flatulent colic, worms and piles.
The flowers are reported to possess astringent,  diuretic,  depurative, 
aphrodisiac and tonic properties; they are used as an emmenagogue and as 
poultice in orchitis and to reduce swellings for bruises and sprains. They are 
also effective in leprosy, leucorrhoea and gout.58
Fig. 4.1: Exomorphic Feature of whole plant of Butea 
monosperma (L) Toub
5. PHARMACOGNOSTICAL STUDIES
5.1 Introduction:
These are the studies which deal with its morphology, Microscopical, 
and  Physico-chemical  constant  of  the  plant  material,  which  has  the 
Pharmaco-therapeutic property.
5.2. Macroscopical characters: 56
Butea monosperma is a deciduous moderate sized tree with grey bark 
a red gum, Kino, exudes from the bark. 
WOOD: 
The wood is dull white and soft. 
LEAVES:
 The leaves are tripinnately compound. The three leaflets are abovate, 
margins smooth, abaxial surface hairy, adaxial surface glabrous.
FLOWERS:
 The flowers are densely fascided, flowers bright red, large and showy 
(fig. 1). The sepals are five gamosepalous, valvate in aestivation, petals are 
five, differentiated into one standard petal,  two wing petals and two keel 
petals,  aestivation  unilencate.  Stamens-  ten  stamens,  diadelphous  with  a 
stamens in bundle and 10th stamen being solitary,  overy- monocarpellary, 
many ovules on marginal placentation. 
SEEDS:
 Seeds are elliptical, reddish brown seed coat and hard.
SHOOT:
 Shoots are clothed with gray or brown silky pubescence.
5.3. Microscopical features:
5.3.1. Introduction: 
 Microscopy is an important tool in the evaluation of crude drugs which is 
applicable at various levels such as the authentification of crude drugs, study 
of powdered drugs, calcium oxalate crystals, starch grains, pollen grains etc. 
Ash values, extractive values and foaming index are used for the study of 
physical properties.
Arrangement of plant into groups and subgroups is commonly spoken as 
classification.  Various  systems  of  classifying  plants  have  gradually 
developed during past few centuries, which have emerged as a discipline of 
botanical  science  known  as  taxonomy  or  systemic  botany.  The  word 
‘taxonomy’  is  derived  from  two  Greek  words  ‘Taxis’  meaning  as 
arrangement and ‘Nomas’ meaning laws. Therefore, the systemization of our 
knowledge about  plants  in  an orderly manner  becomes subject  matter  of 
systematic botany. 57
The aim and objective of taxonomy is to discover the similarities and 
differences  in  the  plants,  including  their  closed  relationship  with  their 
descents from common ancestry. It is a scientific way of naming, describing 
and arranging the plant in an orderly manner.
5.3.2 Materials and Methods for Anatomical studies:
            The Plant Care was taken to select healthy plants and for normal 
organs. The required samples of different organs were cut and removed from 
the plant and fixed in FAA (Formalin – 5ml + Acetic acid – 5ml + 70% Ethyl 
alcohol – 90ml). After 24 hrs of fixing, the specimens were dehydrated with 
graded series of tertiary-Butyl alcohol as per the schedule given by Sass, 
1940.  Infiltration  of  the  specimens  was  carried  by  gradual  addition  of 
paraffin  wax  (melting  point  58-60  C)  until  TBA solution  attained  super 
saturation.  The specimens were cast into paraffin blocks.
A. Sectioning: 
The paraffin  embedded specimens were sectioned with the help of 
Rotary Microtone. The thickness of the section was 10-12 µm. Dew axing of 
the sections  was by customary procedure (Johansen,  1940).  The sections 
were stained with Toluidine blue as per the method published by O’Brien et 
al. (1964). Since Toluidine blue is a polychromatic stain, the staining results 
were remarkably good; and some cytochemical reactions were also obtained. 
The dye rendered pink color to the cellulose walls, blue to the lignified cells, 
dark green to suberin, violet to the mucilage, blue to the protein bodies etc., 
wherever necessary sections were also stained with safranin and Fast-green 
and IKI (for Starch) 56,59.
For studying the stomatal morphology, venation pattern and trichomes 
distribution, paradermal sections (sections taken parallel to the surface of 
leaf)  as well as clearing of leaf with 5% sodium hydroxide or  epidermal 
peeling by partial  maceration employing Jeffrey’s maceration fluid (Sass, 
1940) were prepared. Glycerin mounted temporary preparations were made 
for macerated/cleared materials. Powdered materials of different parts were 
cleared  with  NaOH  and  mounted  in  glycerin  medium  after  staining. 
Different cell component were studied and measured. 59,60
B. Photomicrographs: 
  Microscopic  descriptions  of  tissues  are  supplemented  with 
micrographs  wherever  necessary.  Photographs  of  different  magnifications 
were  taken  with  Nikon  Labphot  2  Microscopic  Unit.  For  normal 
observations bright field was used.  For the study of crystals, starch grains 
and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized light they appear bright against dark 
background. Magnifications of the figures are indicated by the scale-bars. 
Descriptive terms of the anatomical  features are as given in the standard 
Anatomy books (Esau, 1964). 61
5.3.4 Anatomy of Leaf: 
Leaflets: 
The leaflets are dorsiventral with prominently projecting lateral veins 
(fig. 2.1), thick midrib (fib. 3) and bilateral lamina (fig. 2.2).
The lamina has even and smooth adaxial surface and uneven abaxial. 
Surface (fig. 2.2). It is 170 um thick. The adaxial epidermis has rectangular 
or  squarish  cells  with  prominent  cuticle.  The  cells  are  20um thick.  The 
abaxial side has narrow epidermis with cylindrical, cuticularised cells.
The  mesophyll  tissue  is  characteristic  is  having  a  wide  zone  of 
palisade cells comprising of  two layers narrow cylindrical  compact  cells. 
The palisade zone is 90 um in height. Beneath the palisade zone is a single 
horizontal layers of rectangular hyaline parenchyma cells.
The abaxial part of the lamina consists of a single row of palisade 
cells. These abaxial cells are cylindrical and vertical and loosely arranged 
with wide air spaces. The abaxial palisade zone is 30um in height.
The  lateral  vein  has  prominent  collateral  vascular  strand  with  in 
abaxially  projecting  part.  The  vascular  strand  is  covered  by  thick 
paranchymatous bundle sheath which extends adaxially into a thick vertical 
coloumn (fig. 2.1)
The veinlets also have prominent vascular strand and paranchymatous 
bundle sheath and adaxial and abaxial extensions (fig. 2.2).
Midrib:
 The midrib is very thick having adaxial, broadly conical hump and 
more or less wide circular abaxial part. The midrib is 1.1mm thick in vertical 
plane.  The  adaxial  hump is  200um in  height  and  450um in  width.  The 
abaxial part is 1.1mm wide. (Fig. 3)
The epidermal layers of the midrib are thin with small squarish cells 
and  thick  cuticle.  the  ground  tissue  consist  of  about  three  layers  of 
collenchymas and four or five layers of parenchyma, same of the cells in the 
abaxial part are crushed forming thin dark line.
The  vascular  system  is  complex  (fig.  3,6.1).  It  has  wide  hollow 
cylinder  occupying  the  major  area  of  the  midrib.  The  vascular  cylinder 
consists of a thick circular cylinder of sclerenchyma. The cylinder encloses a 
wide and deep abaxial urn-shaped bond of five vascular. Segments, a short 
arc of adaxial segment and two centrally placed circular vascular strands. 
The  vascular  strands  have  short  closely  arranged  radial  rows  of  wide, 
angular thick walled xylem elements; each segment has thick arc of phloem 
on the outer part.
The metaxylem elements are 30-35um wide.
Venation pattern:
The  lateral  veins  and  vein  lets  are  thick  and  straight.  They  form 
narrow but distinct vein islets which are polygonal in outline and random in 
orientation. Some of the islets have no vein terminations while others have 
short thick, straight unbranched terminations. (Fig. 4.1,2)
Epidermal Cells and Stomata: 
The epidermal cells are narrow in area; their anticlinal walls are thin 
and  wavy.  The  stomata  are  paracytic  type  with  equal  or  unequal  lateral 
subsidiary cells. The guard cells are elliptical or circular measuring 15x20 
um in size. (Fig. 5.1, 2)
5.3.5 Powders Microscopy:
Epidermal  trichomes are  abundant  on the abaxial  leaf  surface.  The 
trichomes are unicellular, unbranched, narrow, and thin walled and pointed 
at the tip. The trichomes are glandular type (Fig. 6.2). They are up to 60um 
long and less than 5um thick. The cell walls are smooth.
Petiole (Rachis) (fig.7.1, 2):
 The petiole is circular in outline, the dorsiventral, symmetry is not 
evident. It has thin epidermal layers of small, thick walled cells and fairly 
wide outer paranchymatous ground tissue. The vascular system is complex, 
possessing a continuous ridged outer cylinder and central excentric group of 
discrete strands. The outer cylinder consist of several wedge shaped vascular 
segments,  arranged  closely  appearing  as  continuous  cylinder.  A  thick 
sclerenchyma are occurs on the outer part of each segment (fig. 7.2). The 
central  groups  of  vascular  strands  are  random in  orientation  and  closely 
crowded. Each segment has its own. Phloem and sclerenchyma cap.
Fig. 1: Exomorphic features of the Leaf and Flowers 
of Butea monosperma (L) Toub
Fig. 2: Anatomy of the lamina:-
1. T.S. of lamina through lateral vein
2. T.S. of lamina
(AbE  –  Abaxial  epidermis,  AbP  –  Abaxial  palisade,  AdE  –  Adaxial 
epidermis, AdP – Adaxial palisade, BSE – Bundle sheath extension, La – 
Lamina, Lv – Lateral Vein, MT – Mesophyll tissue, VB – Vascular bundle, X 
– Xylem 
Fig.3: Structure of Midrib: 
(AbB – Abaxial bundle, AdB – Adaxial bundle, AdH – Adaxial hump, CB – 
Central bundle, Col – Collenchyma, Ep – Epidermis, GT – Ground tissue, 
Ph – Phloem, Sc – Sclerenchyma, X – Xylem).
Fig. 4: Venation pattern:
(1) Cleared leaf showing vein islets and vein – termination
(2) Enlarged feature showing vein islets and vein – termination
(VI – Vein  islets, VT – Vein - termination).
Fig. 5: Stomatal Morphology:
1,2. Para dermal section showing abaxial epidermis with stomata
(EC – Epidermal cell, SC – Subsidiary cells, St – Stomata)
Fig. 6: Crystal distribution and powder microscopy of 
the leaf:
(1) T.S.  of  leaf  showing  crystals  in  the  mesophyll  tissue  (under 
polarized light microscope).
(2) Non-glandular epidermal trichomes in the leaf powder.
(Abs – Abaxial side, Ads – Adaxial side, CB – Central bundle, GT – Ground 
– tissue, La – Lamina, Sc – Sclerenchyma, X – Xylem).
Fig. 7: Anatomy of the rachis:
(1) T.S. of rachis entire view.
(2) T.S. of rachis a sector enlarged.
(CVS – Central vascular strand, Ep – Epidermis, GT – Ground tissue, MVS 
– Median vascular cylinder, Ph – Phloem, Sc – Sclerenchyma, X – Xylem
6. PHYTOCHEMICAL STUDIES
6.1 Introduction:
Plants may be considered as biosynthetic laboratories in which various 
kinds  of  organic  compounds  are  synthesized  such  as  Carbohydrates, 
Proteins,  Lipids,  Flavonoids,  Glycosides,  Alkaloids,  Volatile  oils,  and 
Tannins etc., which exert a physiologic effect and are utilized as biologically 
active components by men since time immemorial. The medicinal value of 
any  plant  drug  however  depends  on  the  nature  of  chemical  constituents 
present in it and is referred to as active principle.67
For our present study, we had taken of Butea Monosperma (L) Toub to 
extract  the  active  constituents  are  tested  the  phytochemical  constituents 
present in them.
For  the  isolation  of  compounds,  we  were  using  chromatographic 
techniques by developing various solvent systems and confirm the active 
compounds present in them by different spectral studies.
6.2. Purification of Solvents:
Ethanol
       Method I:  A dry round bottom flask was fitted with a double surface 
condenser  and  a  calcium  chloride  guard  tube.  Dry  magnesium  turnings 
(5mg) and iodine (0.5 gm) were placed in the flask followed by 50-75ml of 
commercial absolute alcohol. The mixture was warmed until the magnesium 
is converted to ethanolate, then 900ml of commercial absolute alcohol was 
added and refluxed for 30 minutes. The ethanol is distilled into vessel and 
used. 
Method II: rectified spirit was soaked in slaked lime for over night distilled 
and used.
Hexane
For the purification of the hexane, it was refluxed for 4 hrs and distilled. 
The distilled  was shaken with  sufficient  amount  of  anhydrous  potassium 
carbonate,  filtered  and  re-distilled.  The  fraction  boiling  at  68°C  was 
collected and used.
Chloroform
The chloroform was shaken well with equal volume of distilled water 
twice to remove water-soluble impurities and separated by using separating 
funnel.  It  was  then dried  over  anhydrous  calcium chloride  for  24 hours, 
filtered  and  dried  once  again  with  anhydrous  potassium  carbonate  for 
another 24 hours.  This was decanted and distilled; the fraction boiling at 
64°C was collected and stored in an amber colored bottle.
Distilled Water 
Water obtained by distillation is used for aqueous extraction of powdered 
drug material. 
Ethyl acetate
It was refluxed for 4 hours and distilled. The distillate was shaken with 
sufficient  amount  of  anhydrous  potassium  carbonate,  filtered  and  re-
distilled. The fraction boiling at 77°C was collected and used.68
6.3. Preparation of Extracts:
Preparation of extracts of Butea monosperma (L) Toub powdered leaves 
by using following solvents: 
(a) Ethanol
(b) Distilled Water
(c) Hexane
(d) Chloroform
(e) Ethyl acetate
Ethanol extract
About  250gm of  dried  leaf  powder  of  each  of  the  species  was  taken 
separately in a Soxhlet apparatus and extracted exhaustively with 750 ml of 
70% ethanol  until  the color  of  siphon changes,  the extracts  was filtered, 
cooled and concentrated under pressure in a rotary evaporator to a syrupy 
consistency followed by dried using a freeze dryer, the percentage yields of 
each plant are given in table no. 4. All the extracts were stored in air-tight 
container until further use.
Aqueous extract
The shade dried coarse powder of the leaves (250gm) was packed well in 
Soxhlet  apparatus  and  was  subjected  to  continuous  hot  extraction  with 
distilled water until the completion of extraction. The extract was filtered 
while hot and the resultant extract was distilled in vacuum under reduced 
pressure in order to remove the distilled water  completely.  It  was finally 
dried and kept in a desiccators till experimentation. Obtained extract was 
weighed and percentage yield was calculated in terms of air-dried powdered 
crude material.
The  yield  and  %  yield  of  both  ethanolic  and  aqueous  extracts  of 
powdered leaves Butea monosperma (L) Toub were reported
Hexane extract:
The shade dried coarse powder of whole plant (250 gm) was packed well in 
Soxhlet  apparatus  and  was  subjected  to  continuous  hot  extraction  with 
hexane for 18 hours.  The extract  was filtered while hot and the resultant 
extract was distilled in vacuum under reduced pressure in order to remove 
the  solvent  completely.  It  was  dried  and  kept  in  a  desiccators  till 
experimentation. Obtained extract was weighed and % yield was calculated 
in terms of air-dried powdered crude material.
Chloroform extract:
The shade dried coarse powder of whole plant (250 gm) was packed well 
in Soxhlet apparatus and was subjected to continuous hot extraction with 
chloroform for 18 hours. The extract was filtered while hot and the resultant 
extract was distilled in vacuum under reduced pressure in order to remove 
the  solvent  completely.  It  was  dried  and  kept  in  a  desiccators  till 
experimentation. Obtained extract was weighed and % yield was calculated 
in terms of air-dried powdered crude material
Ethyl acetate extract:
The shade dried coarse powder of whole plant (250 gm) was packed well 
in Soxhlet apparatus and was subjected to continuous hot extraction with 
ethyl acetate 18 hours. The extract was filtered while hot and the resultant 
extract was distilled in vacuum under reduced pressure in order to remove 
the solvent  completely.  It  was  dried and desiccators  till  experimentation. 
Obtained extract was weighed and % yield was calculated in terms of air-
dried powdered crude material. 64
TABLE NO. 4
EXTRACTIVE VALUES OF EXTRACTS OF POWDERED 
LEAVES OF BUTEA MONOSPERMA (L) TOUB.
S. No Extracts Yield (in gm)
Yield           % 
(W/W)
1. Hexane 4.17 1.67
2. Chloroform 7.95 3.18
3. Ethanol 9.36 3.75
4. Ethyl acetate 10.5 4.20
5. water 5.93 2.37
6.4 Qualitative Phytochemical Analysis: 64,65,69
  All the extracts obtained by the powdered leaves of Butea Monosperma 
(L) Toub.  were subjected to various qualitative tests for the identification of 
phytoconstituents present.
Test for Alkaloids:
(a) Dragendorff’s  test:   To  the  1  ml  of  extract,  add  1  ml  of 
Dragendorff’s  reagent  (potassium  bismuth  iodide  solution).  An 
orange-red precipitate indicates the presence of alkaloids.
(b) Mayer’s test:  To the 1 ml of extract, add 1 ml of Mayer’s reagent 
(Potassium  mercuric  iodide  solution).  Whitish  yellow  or  cream 
coloured precipitate indicates the presence of alkaloids.
(c) Hager’s  test:  To  1  ml  of  extract  add  3ml  of  Hager’s  reagent 
(saturated  aqueous  solution  of  picric  acid)  yellow  colored 
precipitate indicates the presence of alkaloids.
(d) Wagner’s  test:  To  the  1  ml  of  extract  add  2  ml  of  Wagner’s 
reagent (iodine in potassium iodide) formation of reddish brown 
precipitate indicates the presence of alkaloids.
Test for Saponins:
 Take small quantity of alcoholic and aqueous extract separately and 
add 20 ml of distilled water and shake in a graduated cylinder for 15 minutes 
lengthwise. No layer of foam indicates the absence of saponins.
Test for Glycosides:
(a) Legal’s  test:  Dissolve  the  extract  in  pyridine  and  add  sodium 
nitroprusside solution to make it alkaline. No formation of pink to 
red colour shows absence of glycosides.
(b) Baljet’s test:  To 1ml of the test extract, add 1ml of sodium picrate 
solution  and the  yellow to  orange color  reveals  the  presence  of 
glycosides.
(c) Keller-Killiani test:  1gm of powdered drug is extracted with 10ml 
of 70% alcohol for 2 minutes, filtered, add to the filtrate, 10ml of 
water and 0.5ml of strong solution of lead acetate and filtered and 
the filtrate is shaken with 5ml of chloroform. The chloroform layer 
was separated in a porcelein dish and removes the solvent by gentle 
evaporation. Dissolve the cooled residue in 3ml of glacial acetic 
acid containing 2 drops of 5% ferric chloride solution. Carefully 
transfer this solution to the surface of 2ml of concentrated sulphuric 
acid. A reddish brown layer forms at the junction of the two liquids 
and the upper layer slowly becomes bluish green, darkening with 
standing.
(d) Borntrager’s test:  Add a few ml of dilute Sulphuric acid to 1ml of 
the  extract  solution.  Boil,  filter  and  extract  the  filtrate  with 
chloroform. The chloroform layer is treated with 1ml of ammonia. 
The  formation  of  red  color  of  the  ammonical  layer  shows  the 
presence of anthraquinone glycosides.
Test for Carbohydrates: 
(a) Molisch’s  test:  To  2ml  of  the  extract,  add  1ml  of  α-naphthol 
solution, add concentrated sulphuric acid through the side of the 
test tube. Purple or reddish violet color at the junction of the two 
liquids reveals the presence.
(b) Fehling’s  test:  To  1ml  of  the  extract,  add  equal  quantities  of 
Fehling solution A and B, upon heating formation of a brick red 
precipitate indicates the presence of sugars.
(c) Benedict’s test:  To 5ml of Benedict’s reagent, add 1ml of extract 
solution  and  boil  for  2  minutes  and  cool.  Formation  of  red 
precipitate shows the presence of sugars.
Test for Tannins: 
(a) Take the little quantity of test solution and mixed with basic lead 
acetate  solution.  Formation  of  white  precipitates  indicates  the 
presence of tannins.
(b) To 1ml of the extract, add ferric chloride solution, formation of a 
dark blue or greenish black color product shows the presence of 
tannins.
(c) The little  quantity of  the extract  is  treated with potassium ferric 
cyanide  and  ammonia  solution.  A deep  red  color  indicates  the 
presence of tannins.
(d) To the  test  extract,  add strong potassium dichromate  solution,  a 
yellow  color  precipitate  indicates  the  presence  of  tannins  and 
phenolic compounds.
Test for Flavonoids:
(a) The  drug  in  alcoholic  and  aqueous  solution  with  few  ml  of 
ammonia  is  seen  in  U.V.  and  visible  light;  formation  of 
fluorescence indicates the presence of flavonoids.
(b) Little  quantity  of  extract  is  treated  with  amyl  alcohol,  sodium 
acetate  and  ferric  chloride.  A  yellow  color  solution  formed, 
disappears  on  addition  of  an  acid  indicates  the  presence  of 
flavonoids.
(c) Shinoda’s Test:  The alcoholic extract is treated with magnesium 
foil  and concentrated HCl give intense cherry red color indicates 
the  presence  of  flavonones  or  orange  red  color  indicates  the 
presence of flavonols.
(d)The extract is treated with sodium hydroxide; formation of yellow 
color indicates the presence of flavones.
(e) The extract is treated with concentrated H2SO4, formation of yellow 
or orange color indicates flavones.
(f) The  alcoholic  and  aqueous  extract  is  treated  with  10%  sodium 
chloride;  formation  of  yellow  color  indicates  the  presence  of 
coumarins.
Test for Steroids: 
(a) Libermann-Burchard  test:  1gm  of  the  test  substance  was 
dissolved in a few drops of chloroform, 3ml of acetic anhydride, 
3ml of glacial acetic acid were added, warmed and cooled under the 
tap and drops of concentrated sulphuric acid were added along the 
sides of the test tube. Appearance of bluish-green color shows the 
presence of sterols.
(b) Salkowski test:  Dissolve the extract in chloroform and add equal 
volume of conc. H2SO4 .  Formation of bluish red to cherry color in 
chloroform layer and green fluorescence in the acid layer represents 
the steroidal components in the tested extract. 
Test for Proteins:
(a) Biuret test:  Add 1ml of 40% sodium hydroxide solution and 2 
drops of 1% CuSO4 solution till a blue color is produced, and then 
add to the 1ml of the extract. Formation of pinkish or purple violet 
color indicates the presence of proteins.
(b) Ninhydrin test:  Add two drops of freshly prepared 0.2% ninhydrin 
reagent (0.1% solution in n-butanol) to the small quantity of extract 
solution and heat. Development of blue color reveals the presence 
of proteins, peptides or amino acids.
(c) Xanthoproteic test: To 1ml of the extract, add 1ml of concentrated 
nitric acid. A white precipitate is formed, it is boiled and cooled. 
Then 20% of sodium hydroxide or ammonia is added. Orange color 
indicates the presence of aromatic amino acids.
(d) Millon’s test:  1ml of test solution is made acidify with sulphuric 
acid  and  add  Millon’s  reagent  and  boil  this  solution.  A yellow 
precipitate is formed indicates the presence of protein.
Test for Terpenes:
(a) Noller’s test:  Dissolve two or three granules of tin metal in 2ml 
thionyl chloride solution. Then add 1ml of the extract into test tube 
and warm, the formation of pink color  indicates the presence of 
triterpenoids.
Test for Gums: 
Add about 10ml of aqueous extract slowly to 25ml of absolute alcohol 
with  constant  stirring.  Filter  the  precipitate  and  dry  in  air.  Examine  the 
precipitate for its swelling properties and for the presence of carbohydrates.
TABLE NO.5
QUALITATIVE PHYTOCHEMICAL ANALYSIS OF 
ETHANOLIC AND AQUEOUS EXTRACTS OF 
POWDERED LEAVES OF BUTEA MONOSPERMA (L) 
TOUB.
Phytoconstituents
Hexane 
extract
Ethyl 
acetate
Chloroform 
extract
Ethanolic 
extract
Aqueous 
extract
Alkaloids Absent Absent Present Present Present
Saponins Absent Absent Absent Absent Absent
Glycosides Absent Absent Absent Absent Absent
Carbohydrates Present Present Present Present Present
Tannins Absent Absent Absent Present Present
Flavonoids Absent Present Absent Present Present
Steroids Present Absent Absent Present Absent
Proteins Present Absent Absent Present Present
Terpenoids Present Present Absent Absent Absent
Fats Present Absent Absent Absent Absent
6.5. Chromatographic studies:
Chromatography is a technique for separation of the compounds of 
mixtures by their continuous distribution between two phase, one of which is 
moving past the other. The main principle of the separation may be either 
partition  or  adsorption.  The  aqueous  and  ethanolic  extracts  of  various 
individual plants and its formulation were subjected to Thin Layer and High 
Performance  Thin  Layer  Chromatographic  studies  for  the  separation  and 
identification of their components.
6.5.1 Thin Layer Chromatography (TLC):
Thin  layer  chromatography  is  an  important  analytical  tool  in  the 
separation,  identification  and  estimation  of  different  components.  Here, 
when we spot a mixture of components on a TLC plates, the compounds, 
which are readily soluble but not strongly adsorbed moves up along with the 
solvent and those not so soluble but more strongly adsorbed move up less 
readily leading to separation of compounds. 
Steps involved in TLC:
 Plate preparation with appropriate adsorbent
 Activation of adsorbent
 Sample application as spots over the chromatographic plate 
 Solvent system selection
 Detecting agent/ ultra violet light
 Qualitative/Quantitative analysis
Procedure :
 Silica gel G was weighed in required quantity.
 Homogeneous slurry was made with sufficient distilled water.
 Then the slurry was poured into TLC glass plates by spreading 
technique and the uniform silica gel layer was adjusted to 0.25 mm 
thickness.
 The  coated  plates  were  allowed  to  dry  in  air  and  activated  by 
heating in hot air oven at 100-105°c for 1 hour and then used for 
TLC.
 The extracts were prepared with the respective solvent like ethanol 
and distilled water and made up to 10ml in different test tubes.
 Then with the help of capillary tube an extract was spotted on TLC 
plates,  which  were  developed  in  TLC  chamber,  previously 
saturated with different solvent systems.63,65,70
     By trail  and error  method,  ethanol  and aqueous extracts  showed 
isolation and resolution of spots with following solvent systems: 
1. Toluene : Ethyl acetate  7: 3 
2. Petroleum ether: Ethyl acetate: Anhydrous formic acid 70:25:1
    The different spots developed were identified under UV light (λ= 254 
nm) and the Rf value were correspondingly calculated and tabulated as:
TABLE NO -6
    TLC OF ETHANOLIC AND AQUEOUS EXTRACTS
 OF LEAVES OF BUTEA MONOSPERMA (L) TOUB.
S. NO  Extracts Solvent
Systems
No. 
of 
spots
Rf 
Values
1. Ethanolic Extract
1.  Toluene  :  Ethyl 
acetate  7: 3 3
0.39
0.56
0.78
2. Aqueous Extract
2.    Petroleum 
ether:Ethyl  acetate 
:Anhydrous formic 
acid 70:25:1
2 0.190.32
6.5.2 High Performance Thin Layer Chromatography (HPTLC) 
Introduction: 
   High  Performance  Liquid  Chromatography  (HPLC),  High 
Performance  Thin  Layer  Chromatography  (HPTLC)  and  Capillary 
Electrophoresis  are  the  most  widely  used  separation  technique  to 
establish  fingerprint  of  the  herbs,  against  which  raw material  can  be 
evaluated and finished products can be analyzed. 
 High Performance Liquid Chromatography also known as planar 
chromatography  is  a  modern  powerful  analytical  technique  with 
separation  power,  performance  and  reproducibility  superior  to  classic 
TLC.  Based  on  the  use  of  High  Performance  TLC plates  with  small 
particle  size  (3-5  µm)  and  precise  instruments  for  each  step  of  the 
chromatographic  process  (sample  application,  chromatogram 
development, chromatogram evaluation), HPTLC provides the means not 
only for flexible screening procedure and qualitative analysis but also for 
demanding quantitative determination.
While  traditional  TLC  often  relies  on  visual  inspection  of  the 
chromatographic  plate  and  its  documentation  by  either  tracing  or 
photography,  HPTLC  features  highly  sensitive  scanning  densitometry 
and  video  technology  for  rapid  chromatogram  evaluation  and 
documentation. Today most HPTLC instruments are computer controlled 
and  can  therefore,  offer  dramatically  improved  reproducibility  of  the 
analytical result. At the same time HPTLC is still as flexible and friendly 
as classic TLC, but provides even greater advantages.
It  is  very  useful  in  the  qualitative  and  quantitative  analysis  of 
pharmaceuticals. It enjoys a practical application status, as it combines 
the art of chromatography with quickness at a moderate cost. HPTLC is a 
major advancement of TLC principle requiring shorter time and better 
resolution. The basic difference between conventional TLC and HPTLC 
is only in particle and pore size of the adsorbants.
The plates are similar to conventional TLC plates. Layers of HPTLC 
plates are available in the form of precoats.  Silica gel G of very fine 
particle size is widely used as adsorbent in HPTLC for stationary base. 
The use of smaller particle size helps in greater resolution and sensitivity. 
About  3.5  cm  solvent  front  migration  is  sufficient  to  effect  proper 
separation.  Whatman HPTLC plates are produced from 4-5 cm silica gel 
with an inert binder to form a 200-cm layer.
Sample preparation in HPTLC needs a high concentrated solution, as 
very less amount of sample need to be applied. HPTLC is rapidly gaining 
importance  in  biochemistry  of  natural  products  and  in  analysis  of 
biofluids in the field of  pharamacokinetics.  The analytical  profiles  for 
cardenolides, flavonoids, alkaloids, steroidal compounds etc. have been 
developed using the technique.
HPTLC is now days applied to obtain ‘finger print’ patterns of herbal 
formulations,  quantification of active ingredients and also detection of 
adulteration.
Purpose of doing HPTLC:
 To perform qualitative determination and quantitative analysis of 
herbal extracts and synthetic drugs.
 To standardize herbal extracts & formulation
 To perform stability studies of herbal extracts
 To estimate synthetic / natural drugs in formulation
Principle:
   The principle of the separation is adsorption. The components move 
according to their affinities towards the adsorbent. The component with 
more affinity towards the stationary phase travels slower and with lesser 
affinity towards the stationary phase travels faster. Thus the components 
are separated in a thin layer chromatographic plate based on the affinity 
of the component towards phase.
The different operations involved in HPTLC are as follows:
Sample Application:
Sample volume that can be applied spot wise in one stroke are 0.5 to 5 
micro litres on conventional layers and 50 to 500 nano litres of HPTLC 
layers.  Larger volumes can be applied either spot wise or sprayed in the 
form of narrow bands.
Narrow  –band  sample  application  ensures  the  highest  resolution 
attainable with the plate/solvent combination. After all samples have been 
applied, the plate is developed over a short distance with a solvent of 
very high elution power.  In this way, the rectangular sample zones are 
focused into narrow bands.
Chromatogram Development:
When  dipping  in  a  suitable  solvent  develops  a  thin  layer 
chromatogram,  the  solvent  rises  in  the  layer  by  capillary  action  and 
separates the samples into their components parts.   After  reaching the 
solvent from the desired height the run is terminated.
Densitomteric Chromatogram Evaluation:
TLC Scanner  is  the  most  advanced work station  for  densitometric 
evaluation  of  thin  layer  chromatograms.   It  is  designed  for  the 
densitometric  evaluation  of  both  TLC  and  electrophoresis  objects. 
Scanning  is  performed  in  reflectance  or  transmittance  mode,  by 
absorbance or by fluorescence.  The Scanner transmits all measurement 
data  in  digital  form to  the  computer  for  further  processing.   Spectra 
recorded  by  the  user  are  stored  in  the  library.   Correlation  between 
spectra  can  be  calculated  and  displayed.  All  methods  can  be  run 
automatically.
Post Chromatographic Derivatization:
UV light  is  the first  choice  for  visualization  and for  densitometric 
determination of the separated substances on the chromatogram.  If the 
fractions do not respond to UV radiation, suitable reagents are applied to 
the chromatogram.  For the transfer of liquid reagent,  one can choose 
between spraying or dipping.  Dipping transfer appreciably more liquid 
than spraying.
Procedure:
     The aqueous and ethanolic  (70%) extracts of Butea monosperma (L)  
Toub.  K.  Presl  was  subjected  to  High  Performance  Thin  Layer 
Chromatography analysis in order to identify the chemical constituents. 
 Camag Linomat spotted the precoated silica gel G60 of 10 X 10cm 
with 10 micro liter of extract.
 The  plate  was  developed  in  the  solvent  system,  Hexane:  acetone: 
chloroform (5:3:3)  for  ethanolic  extract  and Acetone:  water:  acetic 
acid (5:5:0.5) for aqueous extract in Camag twin through chamber.
 The  developed  plates  were  taken  out,  dried  and  were  scanned  by 
Camag TLC Scanner. 
 Detection was done under UV light spots of fluorescent compounds, 
at 254 nm.71,72
TABLE NO. 7
DATA FOR HPTLC OF AQUEOUS AND 
ETHANOLIC EXTRACTS OF LEAVES OF BUTEA 
MONOSPERMA (L) TOUB.
Extracts
No.  of 
peaks
Rf values % Area
Ethanolic 
Extract 8
0.03,  0.05,  0.12, 
0.19,  0.42,  0.59, 
0.69, 0.78.
1.58,  1.22,  1.77, 
7.83,  31.50, 
21.66,  18.84, 
15.59.
Aqueous 
Extract 9
0.04,  0.16,  0.21, 
0.45,  0.62,  0.75, 
0.82, 0.86, 0.92.
6.20,  23.68, 
12.78,  7.84, 
10.71,  12.78, 
6.75, 13.40, 5.89.
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7. PHARMACOLOGICAL STUDIES
7.1 Acute Oral Toxicity study:
By following  OECD (Organization  of  Economic  Co-operation  and 
Development)  guidelines  420-  Fixed Dose  Procedure  (FDP),  acute  oral 
toxicity  was  evaluated.  This  involves  the  identification/calculation  of  the 
doses level  that  becomes evidence of  non-lethal  toxicity (termed Evident 
toxicity),  which  gives  clear  signs  and  symptoms  of  toxicity  of  a  test 
drug/substance.  When dose where increase to  next level  of  highest  fixed 
dose, which would result in the development of severe toxicity sign or even 
death. Next highest fixed dose producing, Evident toxicity was assumed and 
was  also  calculated  on  ones  experiences.  These  doses  also  provide 
information that lead to a similar classification, to that based on the LD50 
value.
Procedure:
 Five animals (Wister Albino rats, 150-200 gm) were selected for 
studies.
 Then the defined or fixed dose levels of Ethanolic and Aqueous 
extracts in 50, 100, 200, 500 and 1000 mg/kg was given to identify 
a dose producing evident toxicity.
 After  giving  different  doses,  the  toxicity  signs  were  observed 
within 48 hrs.
 Food was withheld for 3-4 hours after drug administration.
 Further, last highest fixed dose 2000mg/kg body weight was given 
and again sign of toxicity and mortality was observed.
 Most  of  the  crude  extracts  possess  LD50 value  more  than 2000 
mg/kg of the body weight of animal used.
 Dose volume administered was 0.1ml/100gm body weight of the 
animal orally.
 Following was observed; body weights of the rats before and after 
drug  administration,  onset  of  toxicity  and  sign  of  toxicity  like 
change  in  skin  and  fur,  eyes  and  mucous  membrane  and  also 
respiratory, circulatory, autonomic and central nervous system and 
somatomotor  activity,  behavior  pattern,  sign  of  tremors, 
convulsions, salvation, lethargy, sleep and coma was also noted if 
any.73,74
Observation:
No toxicity or death was observed for these given dose levels, in the 
selected  and treated  animals.  So  the  LD50  of  the  Ethanolic  and  Aqueous 
extracts  as  per  OECD  guidelines-420  is  greater  than  2000mg/kg 
(LD50>2000mg/kg). Hence the biological dose was fixed 100 and 200mg/kg 
for both the extracts.
7.2 Antidiabetic activity:
Evaluation of herbal drugs and its therapeutic use involves numerous 
steps  i.e.  starting  from the  proper  selection  and  identification  of  plants, 
collection,  processing,  and extraction  with  different  solvents,  preliminary 
phytochemical  studies  and  evaluation  of  therapeutic  efficacy  on  suitable 
animal model and also its acute toxicity and effective dose studies.
Thus, pharmacological studies are of much importance and only the 
way  for  evaluating  any  herbs/drug  efficacy,  therefore,  considering  its 
importance  we  have  planned  here,  stepwise  evaluation  of  antidiabetic 
potential of ethanolic and aqueous extracts of  Butea monosperma (L) Toub 
including biochemical parameters and its antipyretic potentials as claimed in 
ethnobotanical studies.
Material required:
Experimental models
Male Wister albino rats of 150-200gm were selected fo either sex, for 
studies and they were kept in a standard polypropylene cage at room 
temperature of  27± 2°C, relative humidity 60-70%and well ventilated, they 
were fed a standard rat pellet and water ad-libitum.
Animals were deprived of food initially for 16 hr but had free access 
to water.
Chemical used
Freshly prepared aqueous solution of Alloxan monohydrate, (SD fine 
chemical  Pvt.  Ltd.  Biosar.)  Glibenclamide,  carboxy  methyl  cellulose  and 
text extracts (ethanolic and aqueous).
Screening of Antidiabetic activity:
Induction of Diabetes:
Hyperglycemia/diabetes  was  induced  by  single  intraperitonial 
injection  of  freshly  prepared  aqueous  solution  of  alloxan  monohydrate 
150mg/kg,  to overnight fasted rats.  After  48 hrs  of  alloxan injection,  the 
animals  which  did  not  developed  hyperglycemia  i.e.  glucose 
level>200mg/dl, were rejected/replaced with new animals. Immediately after 
induction of diabetes, rats were classified into five groups of six rats each.
Preparation of Text extracts:
Standard drug used for treatment,  glibenclamide,  5mg/kg, ethanolic 
and aqueous test extracts which is prepared 200mg/kg in 2%carboxy methyl 
cellulose (CMC) and was given orally.
Evaluation of antidiabetic effect of test extracts was done by taking six rats 
in each five groups as,
Group 1: served as normal control (saline).
Group 2: served as diabetic control (alloxan induced).
Group 3 received ethanolic extract, 200mg/kg orally.
Group 4: received aqueous extract, 200mg/kg orally.
Group 5: served as reference standards (Glibenclamide, 5mg/kg).
Treatment was continued for 15 consecutive days, with twice a day 
dose (morning and evening). Before the treatment (0 day) and at the end of 
8th and 15th day, blood samples were collected from the tip of the tail of each 
rat under mild ether anesthesia in 1ml Eppendrof tubes containing 50µl of 
anticoagulant (heparin) and serum separated by centrifugation of blood at 
4000rpm  for  10mins  was  subjected  for  estimating  glucose  by  glucose 
oxidase method using semi auto-analyze.75,76 (Table no. 8)
                             
TABLE NO-8
ANTI-DIABETIC ACTIVITY OF ETHANOLIC AND 
AQUEOUS EXTRACTS
OF LEAVES OF BUTEA MONOSPERMA (L) TOUB
Sampling 
time
Blood glucose (mg/dl)
control Diabetic 
control
Sample A
(Alcoholic 
200mg/kg)
Sample B
(Aqueous)
(200mg/kg
)
Glibenclam
ide
(5mg/kg)
8th day 125.4
±
11.2
352.4
±
11.8
240.8
±
11.6*
236.7
±
12.3*
171.6
±
12.1*
15th day 127.2
±
8.4
351.2
±
11.5
216.3
±
12.2*
198.5
±
12.1*
139.6
±
12.2*
Values are expressed as mean ± S.E.M. (n=6)
*compared to group received standard drug (p<0.001)
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7.3 Anti Inflammatory Activity:
Inflammation:
         “Inflammation is the reaction of vascular supporting elements to injury 
and results in formation of protein rich exudates provided the injuries have 
not been so serious as to destroy the area.”
It  is a localized tissue response to injuries by physical or chemical 
agents.  It  comprises  a  serious  of  phenomena  occurring  partly  in  the 
circulatory system and partly in the tissue in varied proportion.
Carageenan induced hind paw edema:
Albino rats of either sex weighing 150-200gms were divided into six 
groups of six animals each. The dosages of the drugs administered to the 
different groups were as follows. Group1-control,  group 2,3 test drugs  at  a 
dose of 200 mg/kg and group 4-indomethacin (10 mg/kg ) . All the drugs 
were administered orally.
After one our of the administration of the drugs, dose 0.1 ml of 1%w/v 
carrageenan solution in normal saline was  injected in the sub plantar tissue 
of the left hind paw of  the rat and right hind paw served as the control. The 
paw volume of the rats were measured in the digital plethysmograph (ugo 
basile,  italy),  at  the  end  of  0  min,  60min.  and  120min.,  180min.  the  % 
increase in paw edema of the treated group was compared with that of the of 
control  and  the  inhibitory  effect  of  the  drugs  were  studied.  The  relative 
potency of  the drugs under investigations was calculated based upon the 
percentage inhibition of the inflammation.
Discussion:
Edema which develops after carrageenan inflammation is a biphasic 
event. The initial phase is attributed to the release of histamine and serotonin. 
The edema maintained between the first and the second phase is due to kinin 
like substances.  The second phase is said to be promoted by prostaglandin 
like  substances.  It  has  been  reported  that  the  second  phase  of  edema  is 
sensitive to drugs like hydrocortisone, phenylbutazone and indomethacin.
Percentage inhibition:
Control (% increase in paw      -     Test (% increase in paw
             Volume in 3rd hour)                 volume in 3rd hour)
            ---------------------------------------------------------------   × 100
               Control (% increase in paw volume in 3rd hour
Statistical analysis:
The experimental results were expressed as the mean  ±  standard error of 
mean  (SEM)  and  the  statistical  significance  was  evaluated  by  using 
student‘t’ test. The p- values of less than 0.001 imply significance.77,78
TABLE .NO.9
ANTI-INFLAMMATORY ACTIVITY OF ETHANOLIC AND 
AQUEOUS EXTRACTS OF LEAVES OF BUTEA 
MONOSPERMA (L) TOUB ON CARAGEENAN INDUCED 
HIND PAW EDEMA.
Treatment 
(Dose)
% increase  in  paw volume(Mean±  
S.E.M)
% inhibition
in paw
volumePost result time of assay in minutes
0 60 120 180
Control
(0.1 ml/kg)
29.26
±  
1.83
51.92
±
4.86
88.87
±
7.05
112.01
±  
7.52
--
Ethanolic
 extract (100mg/kg)
32.17
±
2.15
43.6
±  
2.69
65.2
±  
2.30
70.7
±
3.32
51.63
Aqueous 
 extract (200mg/kg)
30.28
±    
2.65
41.5  ±  
3.21
49.6  ±  
2.45
59.84*
±  
4.4
        46.37
Indomethacin (10 
mg/kg)
28.2 
±  
1.2
35.79 
±  
1.82
38.6 
±  
2.07
42.2
±  
3.22
65.28
* P <  0.001 Vs control by student‘t’ test.
GRAPH NO-7.2
GRAPHICAL REPRESENTATION OF ANTI-INFLAMMATORY ACTIVITY OF 
ON ETHANOLIC AND AQUEOUS EXTRACTS OF LEAVES Of BUTEA 
MONOSPERMA (L) TOUB ON CARAGEENAN INDUCED HIND PAW EDEMA. 
0
20
40
60
80
100
120
G1 G2 G3 G4
%
 IN
H
IB
IT
IO
N
 IN
 P
A
W
 
V
O
LU
M
E
0 MIN 60 MIN 120 MIN 180 MIN
GRAPH NO-7.3
GRAPHICAL REPRESENTATION OF ANTI-INFLAMMATORY ACTIVITY OF 
ON  ETHANOLIC  AND  AQUEOUS  EXTRACTS  OF  LEAVES Of  BUTEA 
MONOSPERMA (L) TOUB ON CARAGEENAN INDUCED HIND PAW EDEMA. 
%INHIBITION PAW VOLUME
10
20
30
40
50
60
70
80
G1 G2 G3 G4
TREATMENT
%
 IN
H
IB
IT
IO
N
 
V
O
LU
M
E
Y
7.4 Anti-Pyretic Activity:
Introduction
Pyrexia or fever is caused as a secondary impact of infection, tissue 
damage inflammation, graft rejection, malignancy or other diseased status. 
It is the body’s natural defense to create on environment where infectious 
agents or damaged tissue cannot survive.
The antipyretic potential of the  Butea monosperma (L) Toub leaves 
studied by Brewer’s yeast induced pyrexia.
Materials required:
Experimental models – Male rat weighing 200 – 250gms
Chemicals used          – Aqueous suspension of dried Brewer’s 
                                               yeast (12%)
Screening of Antipyretic Activity:
Induction of Pyrexia 
Pyrexia induced by subcutaneous injection of aqueous suspension of 
dried  Brewer’s  yeast  (12%)  rats  developing  1oC  or  more  rise  in  rectal 
temperature at 18th hour after injection were treated with 5% gm acacia.
Preparation of test extract 
Standard drug used for treatment paracetomal (25mg / kg), aqueous 
extract (200mg/kg), ethanolic extract (200mg/kg) were prepared and given 
subcutaneously.
Treatment schedule
 Male rat weighing 200-250 gms were divided in to four groups each 
consisting of six animals (n=6).
Group I : Served as control,
Group II : Received aqueous extract (200mg/kg)
Group III : Received ethanolic extract (200mg/kg)
Group IV : Served as reference standard (Paracetamol- 25mg/kg)
Treatment  continued  for  next  four  hours  after  inducing  pyrexia, 
temperature measured after internal of one hour up to 4th hours.
Experimental Procedure:
Male albino rat weighing 200 – 250gm were injected subcutaneously 
(5ml/kg) aqueous suspension of dried Brewer’s Yeast (12%) Rats developing 
1oC or more rises in rectal temperature at 18th hr after injection were treated 
with 5% gum acacia and served as control.   Group II & III received the 
aqueous  and  ethanolic  extract  (200mg/Kg)  respectively.   Group  IV was 
treated  with  paracetamol  (25mg/Kg)  and  served  as  reference  standard. 
Temperature was recorded at time intervals of 1, 2, 3 & 4 hours.
Percentage decrease in temperature by aqueous extract  (200mg/kg), 
ethanolic extract (200mg/Kg) and standard drug was found to be 3.82, 4.55 
and 4.80 percentages respectively.79
TABLE NO. 10
ANTI –PYRETIC ACTIVITY OF AQUEOUS AND 
ETHANOLIC
S.
N
Treatmen
t
Dose 
Mg/Kg
Normal 
rectal 
temperatur
eOC mean + 
S.E
Temperature 
18hrs after 
Yeast induced 
pyrexia
Temperature after treatments (hours) % 
activity1st
Hour OC
2nd
Hour OC
3rd
Hour OC
4th
Hour OC
1 Control 37.2 + 0.05 38.09 + 0.24 39.6 + 0.05 39.7+0.07 39.9+0.04
1
39.7*+0.06
2
The 
aqueous 
extract
200mg/
Kg
37.3 + 0.09 39.08 + 0.34 38.6 + 0.24
38.8+0.12
38.5+0.09 38.01*+0.06 3.82
3
The 
ethanolic 
extract
200mg/
kg
37.6 + 0.13 39.06 + 0. 72 38.8 + 0.41 38.5+0.20 38.01+0.15 37.8+0.21 4.55
4
Paraceta
mol
25mg/k
g
37.3 + 0.28 38.10 + 0.16 38.5 + 0.28 37.9 + 
0.34
37.9+0.26 37.6*+ 0.17 4.80
EXTRACT OF BUTEA MONOSPERMA (L) TOUB.
  
  n = 6 values as mean + S.E
* P < 0.001 Vs control by student ‘ t ’ test
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8. RESULTS AND DISCUSSION
The powdered leaves of  Butea monosperma (L) Toub. belonging to 
family  Fabaceae  has  been  investigated  in  a  systematic  way  covering 
pharmacognostical,  phytochemical,  and  pharmacological  aspects  in  an 
attempt to rationalize its use as drug of therapeutic importance.
Pharmacognostical studies:
The  macroscopic  and  microscopic  details  of  the  leaves  of  Butea 
monosperma (L) Toub. were investigated.
 In  microscopy,  The  leaflets  are  dorsiventral  with  prominently 
projecting lateral veins, thick midrib and bilateral lamina.
 The midrib is very thick having adaxial, broadly conical hump and more or 
less wide circular abaxial part. The midrib is 1.1mm thick in vertical plane.
The lamina has even and smooths adaxial surface and uneven abaxial 
surface it is 170 um thick. 
The  vascular  system  is  complex,  it  has  wide  hollow  cylinder 
occupying the major area of the midrib. The vascular cylinder consists of a 
thick circular cylinder of sclerenchyma. The lateral veins and vein lets are 
thick  and  straight.  They  form  narrow  but  distinct  vein  islets  which  are 
polygonal in outline and random in orientation.
 The epidermal cells are narrow in area; their anticlinal walls are thin 
and  wavy.  The  stomata  are  paracytic  type  with  equal  or  unequal  lateral 
subsidiary cells. The guard cells are elliptical or circular measuring 15x20 
um in size. Epidermal trichomes are abundant on the abaxial leaf surface. 
The  trichomes  are  unicellular,  unbranched,  narrow,  and  thin  walled  and 
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pointed at the tip. The trichomes are glandular type. They are up to 60um 
long and less than 5um thick. The cell walls are smooth.
 The petiole is circular in outline, the dorsiventral, symmetry is not 
evident. It has thin epidermal layers of small, thick walled cells and fairly 
wide outer paranchymatous ground tissue. The vascular system is complex, 
possessing a continuous ridged outer cylinder and central excentric group of 
discrete strands.
 The physicochemical parameters like total ash value (11.5%w/w), acid 
insoluble  ash  value  (6.5%w/w),  water  soluble  ash  value  (9.5%w/w)  and 
sulphated ash value (10.4%w/w) were observed. Alcohol soluble extractive 
value (2.8%w/w) water  soluble  extractive value (1.9%w/w)  and loss  on 
drying  (4.7%w/w)  were  evaluated  The  above  studies  enable  the 
identification  of  the  plant  material  for  future  investigation  and forms an 
important aspect of drug studies.
Phytochemical studies:
The  leaves  of  Butea  monosperma  (L)  Toub.  was  powdered  and 
successively extracted with hexane, chloroform, ethanol, ethyl acetate and 
distilled water (by  continuous soxhlet extraction) the yields were 1.67 w/w, 
3.18%w/w, 3.75%w/w, 4.20%w/w, 2.37%w/w respectively. All the extracts 
where subjected to phytochemical tests to find out the active constituents. 
Presence  of  alkaloids,  terpenoids,  carbohydrate,  steroids,  flavonoids, 
phenolic compounds, protein and amino acids, fat were identified.
 In ethanolic extract tannins, flavonoids, steroids, alkaloids, protein, 
were  present  and  in  aqueous  extract  alkaloids,  carbohydrates,  tannin, 
flavonoids, protein were present. 
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Ethanoloic  and  Aqueous  extracts  were  subjected  to  Thin  Layer 
Chromatography on silica gel for the identification of chemical constituents. 
Ethanolic extract has shown three spots with Rf value 0.39, 0.56, 0.85. While 
aqueous extract has shown two spots with Rf value 0.19, 0.32.
Ethanoloic  and  Aqueous  extracts  were  subjected  to  HPTLC  for 
identifying the number of chemical constituents present in those extract. In 
Ethanolic extract 8 peaks were observed, in Aqueous extracts 9 peaks were 
observed.
Pharmacological studies:
The acute  oral  toxicity  of  ethanolic  extract  of  the leaves  of  Butea 
monosperma (L) Toub  was carried out as per OECD- 420 guide lines. The 
acute toxicity studies revealed that LD50> 2000mg/kg for the extracts.
Antidiabetic activity: 
In alloxan diabetic rats the blood glucose levels were in the range of 
352-358mg/kg, which was considered as sever diabetes. In the standard drug 
(Glibenclamide 5mg/kg) and aqueous extract (200 mg/kg) treated groups the 
peak values of blood sugar significantly decreased to 216.3mg/kg and 198.5 
mg/kg simultaneously on the 15th day. Thus the aqueous extract was found to 
be  almost  significant  as  standard  drug  in  lowering  blood  glucose  level. 
Where  as  the  ethanolic  extracts  (200mg/kg)  treated  group  showed 216.3 
kg/mg blood glucose level which is comparatively less to aqueous extract 
and standard drug. The drug/extracts were given twice a day dose was found 
significant.
Page 83
Anti-inflammatory activity:
The ethanolic  and aqueous extracts  both possess anti-inflammatory 
activity but the extent of activity was different for different extracts and also 
varied with doses. The ethanolic extracts (200mg/kg) possessed significant 
anti inflammatory activity as the percentage inhibition was 51.63(*p<0.001).
Anti-pyretic activity:
It  was  performed  by  using  the  dried  Brewer’s  Yeast  (12%)  for 
induction of pyrexia and measuring the rectal temperature of male rat.  The 
standard drug was served as paracetamol.  The aqueous extract (200mg/kg), 
ethanolic extract (200mg/kg) were selected for the anti-pyretic study.  The 
results were interpreted by measuring the decrease in rectal temperature after 
given test extracts and standard drug.
Decrease in temperature is observed at 1st, 2nd, 3rd, & 4th hour after the 
treatment with the extract and standard drug tabulated in Table no.10.
         The treated group with leaves of Butea monosperma (L) Toub. both 
extract showed significant percentage reduction in pyrexia (3.82%, 4.55%) 
at  200mg/kg  dose  while  standard  drug  (25  mg/kg)  showed  reduction  in 
pyrexia (4.80%) .   
Page 84
9. CONCLUSION
The plant Butea monosperma (L) Toub. has been examined to gain an 
insight  of  its  pharmacognostical,  phytochemical  and  pharmacological 
behavior.
The  pharmacognostical  studies  include  macroscopical  studies, 
microscopical studies, ash values, extractive values, and loss on drying.        
         The  phytochemical  investigation  showed  the  presence  of 
carbohydrates, alkaloids, tannin, protein and amino acids, fat, phytosterols, 
flavanoids in various extracts.
The findings  were collaborated by TLC and HPTLC studies of  all 
extracts indicate the presence of compounds.
The pharmacological studies showed that aqueous 200mg/kg extract 
showed  significant  antidiabetic  activity.  Surprisingly  ethanolic  200mg/kg 
extracts  has  demonstrated  significant  anti-inflammatory  and  anti-pyretic 
activity.
Therefore  these  studies  are  needed  to  isolate  and  characterize  the 
active  principle  of  Butea  monosperma  (L)  Toub.  which  can  have  offer 
antidiabetic, anti-inflammatory and anti-pyretic properties and to establish 
its mechanism of action. 
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